175 related articles for article (PubMed ID: 34896918)
1. Discovery and characterization of circulating tumor cell clusters in neuroendocrine tumor patients using nanosubstrate-embedded microchips.
Sun N; Yang Y; Miao H; Redublo P; Liu H; Liu W; Huang YW; Teng PC; Zhang C; Zhang RY; Smalley M; Yang P; Chou SJ; Huai K; Zhang Z; Lee YT; Wang JJ; Wang J; Liang IY; Zhang TX; Zhang D; Liang L; Weiss PS; Posadas EM; Donahue T; Hecht JR; Allen-Auerbach MS; Bergsland EK; Hope TA; Pei R; Zhu Y; Tseng HR; Heaney AP
Biosens Bioelectron; 2022 Mar; 199():113854. PubMed ID: 34896918
[TBL] [Abstract][Full Text] [Related]
2. Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells.
Lin M; Chen JF; Lu YT; Zhang Y; Song J; Hou S; Ke Z; Tseng HR
Acc Chem Res; 2014 Oct; 47(10):2941-50. PubMed ID: 25111636
[TBL] [Abstract][Full Text] [Related]
3. NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells.
Jan YJ; Chen JF; Zhu Y; Lu YT; Chen SH; Chung H; Smalley M; Huang YW; Dong J; Chen LC; Yu HH; Tomlinson JS; Hou S; Agopian VG; Posadas EM; Tseng HR
Adv Drug Deliv Rev; 2018 Feb; 125():78-93. PubMed ID: 29551650
[TBL] [Abstract][Full Text] [Related]
4. Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.
Davis AA; Zhang Q; Gerratana L; Shah AN; Zhan Y; Qiang W; Finkelman BS; Flaum L; Behdad A; Gradishar WJ; Platanias LC; Cristofanilli M
Breast Cancer Res; 2019 Dec; 21(1):137. PubMed ID: 31801599
[TBL] [Abstract][Full Text] [Related]
5. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Threshold for Circulating Tumor Cells in Patients With Pancreatic and Midgut Neuroendocrine Tumors.
Mandair D; Khan MS; Lopes A; Furtado O'Mahony L; Ensell L; Lowe H; Hartley JA; Toumpanakis C; Caplin M; Meyer T
J Clin Endocrinol Metab; 2021 Mar; 106(3):872-882. PubMed ID: 33180939
[TBL] [Abstract][Full Text] [Related]
8. Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis.
Sharma U; Medina-Saenz K; Miller PC; Troness B; Spartz A; Sandoval-Leon A; Parke DN; Seagroves TN; Lippman ME; El-Ashry D
Breast Cancer Res Treat; 2021 Aug; 189(1):63-80. PubMed ID: 34216317
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma.
He W; Xu D; Wang Z; Wu H; Xiang X; Tang B; Jiang W; Cui Y; Wang H; Jiang N; Sun Y; Chen Y; Li S; Hou M; Zhang Y; Wang L; Ke ZF
J Transl Med; 2019 Jan; 17(1):32. PubMed ID: 30658713
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cell clusters: What we know and what we expect (Review).
Hong Y; Fang F; Zhang Q
Int J Oncol; 2016 Dec; 49(6):2206-2216. PubMed ID: 27779656
[TBL] [Abstract][Full Text] [Related]
11. Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
Mu Z; Benali-Furet N; Uzan G; Znaty A; Ye Z; Paolillo C; Wang C; Austin L; Rossi G; Fortina P; Yang H; Cristofanilli M
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27706044
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cell clusters: Insights into tumour dissemination and metastasis.
Herath S; Razavi Bazaz S; Monkman J; Ebrahimi Warkiani M; Richard D; O'Byrne K; Kulasinghe A
Expert Rev Mol Diagn; 2020 Nov; 20(11):1139-1147. PubMed ID: 33140979
[No Abstract] [Full Text] [Related]
13. Relevance of CTC Clusters in Breast Cancer Metastasis.
Piñeiro R; Martínez-Pena I; López-López R
Adv Exp Med Biol; 2020; 1220():93-115. PubMed ID: 32304082
[TBL] [Abstract][Full Text] [Related]
14. The identification of a TNBC liver metastasis gene signature by sequential CTC-xenograft modeling.
Vishnoi M; Liu NH; Yin W; Boral D; Scamardo A; Hong D; Marchetti D
Mol Oncol; 2019 Sep; 13(9):1913-1926. PubMed ID: 31216110
[TBL] [Abstract][Full Text] [Related]
15. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.
Wang C; Mu Z; Chervoneva I; Austin L; Ye Z; Rossi G; Palazzo JP; Sun C; Abu-Khalaf M; Myers RE; Zhu Z; Ba Y; Li B; Hou L; Cristofanilli M; Yang H
Breast Cancer Res Treat; 2017 Jan; 161(1):83-94. PubMed ID: 27771841
[TBL] [Abstract][Full Text] [Related]
16. Color-coded Imaging of the Circulating Tumor Cell Microenvironment.
Satake T; Suetsugu A; Nakamura M; Kunisada T; Shimizu M; Saji S; Moriwaki H; Hoffman RM
Anticancer Res; 2018 Oct; 38(10):5635-5638. PubMed ID: 30275181
[TBL] [Abstract][Full Text] [Related]
17. Proportion of circulating tumor cell clusters increases during cancer metastasis.
Suo Y; Xie C; Zhu X; Fan Z; Yang Z; He H; Wei X
Cytometry A; 2017 Mar; 91(3):250-253. PubMed ID: 28009470
[TBL] [Abstract][Full Text] [Related]
18. The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer.
Beltran H; Jendrisak A; Landers M; Mosquera JM; Kossai M; Louw J; Krupa R; Graf RP; Schreiber NA; Nanus DM; Tagawa ST; Marrinucci D; Dittamore R; Scher HI
Clin Cancer Res; 2016 Mar; 22(6):1510-9. PubMed ID: 26671992
[TBL] [Abstract][Full Text] [Related]
19. Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors.
Bodei L; Kidd M; Modlin IM; Severi S; Drozdov I; Nicolini S; Kwekkeboom DJ; Krenning EP; Baum RP; Paganelli G
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):839-851. PubMed ID: 26596723
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
